DEPLOYDatabase

Company

Synchron

Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery.

Founded
2016
HQ
New York, NY, USA

The verified answer

As of Aug 2026, DEPLOY verifies Synchron: 1 model, $200.0M raised. 1 source back the record.

CategoryWearable AI

Overview

Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery. Founded by neurologist Tom Oxley, the company has raised over $345M in total funding including a $200M Series D in 2024. Synchron's COMMAND and SWITCH clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.

Verified record

Verified deployments
None on file
Active incidents
None on file

Key facts

CEO

Tom Oxley (Founder, neurologist, Mount Sinai)

Product

Stentrode (endovascular BCI implant, no open-brain surgery)

Clinical trials

COMMAND (US, FDA-approved), SWITCH (Australia, 4 patients)

Safety

No serious device-related adverse events in 6 patients

Target

Patients with severe paralysis (ALS) to communicate via thought

Data & sources

Web sources

1

1 source backing this record.View all →

Synchron on the deployment map

View the global map

Synchron has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

No verified deployments for Synchron on the DEPLOY record yet. Track Synchron to know the moment the first one is verified.

Free to use on your site, with a link back to DEPLOY.

Current leadership (1)

  • Tom Oxley Founder & CEOreported, not verified

Founders (1)

See all founders across the registry →

Safety record

No incidents on record for Synchron.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Synchron in third-party press

Peer companies